Opko Health Inks Pfizer License Pact By: Benzinga via Benzinga December 15, 2014 at 13:49 PM EST Opko Health Inc. (NYSE: OPK) gained more than 9 percent Monday after the developmental drug company licensed its growth hormone ... Read More >> Related Stocks: Pfizer